| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |